RADA MALINOVIC: Open Payments
NPI 1760531701 · WAUKESHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 8 companies in 2025. Trend: 2023 $402 · 2024 $402 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Braeburn Inc. | 1 | $17 |
Products named: ARISTADA, AUSTEDO XR, SUBLOCADE, Auvelity, INGREZZA, VRAYLAR, COBENFY, BRIXADI.
Industry payments across WI — which companies pay providers there.
